Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.017
+5.88% +0.00
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2021-09-29
Change - Announcement of Cessation::Retirement of Independent Non-Executive Director - Claudia Teo Kwee Yee
2021-09-28
Annual General Meeting::Voluntary
2021-09-28
Annual Reports and Related Documents::
2021-08-23
Financial Statements and Related Announcement::Full Yearly Results
2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang
2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung
2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee
2021-07-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong
2021-07-26
General Announcement::Press Release: iX Biopharma to Export Sublingual Medicinal Cannabis Wafer to New Zealand
2021-07-25
General Announcement::RESULTS OF THE RIGHTS ISSUE AND LISTING AND QUOTATION OF THE RIGHTS SHARES
2021-07-16
Employee Stock Option/ Share Scheme::GRANT OF SHARE OPTION PURSUANT TO iX EMPLOYEE SHARE OPTION SCHEME
2021-07-11
General Announcement::PROPOSED SPIN-OFF AND LISTING OF PHARMACEUTICAL AND MEDICINAL CANNABIS BUSINESS ON THE HKEX
2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Eddy Lee Yip Hang
2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Albert Ho Shing Tung
2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Low Weng Keong
2021-07-06
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities - Teo Kwee Yee
2021-07-05
General Announcement::RIGHTS ISSUE - DESPATCH OF NOTIFICATION AND APPLICATION FORMS
2021-06-30
General Announcement::RIGHTS: OFFER INFORMATION STATEMENT DATED 30 JUNE 2021
2021-06-30
REPL::Rights::Voluntary
2021-06-27
General Announcement::Press Release: iX Biopharma Commences Supply of Medicinal Cannabis Wafers to Brazil
2021-06-22
REPL::Rights::Voluntary
2021-06-21
REPL::Rights::Voluntary
2021-06-14
General Announcement::IX PARTICIPATES IN STUDY: WAFERMINE FOR TREATMENT OF BREAKTHROUGH PAIN IN ADVANCED CANCER PATIENTS
2021-06-08
Rights::Voluntary
2021-06-03
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARD PURSUANT TO iX PERFORMANCE SHARE PLAN
2021-06-01
General Announcement::Press Release: iX Biopharma Expands Wafer Production Capacity to Meet Growing Demand
2021-05-31
Change - Change of Catalist Sponsor::Change of Continuing Sponsor
2021-05-17
General Announcement::Orphan Drug Designation Granted for the Treatment of CRPS with Ketamine to iX Biopharma
2021-02-28
Change - Announcement of Appointment::Appointment of Director of Corporate Affairs
2021-02-28
General Announcement::Press Release: iX Biopharma announces appointment of Director of Corporate Affairs
2021-02-09
Financial Statements and Related Announcement::Half Yearly Results
2021-02-09
General Announcement::ANNOUNCEMENT PURSUANT TO RULE 706A OF THE CATALIST RULES
2021-01-18
Change - Announcement of Appointment::Appointment of Chief Commercial Officer
2021-01-18
General Announcement::Press Release: iX Biopharma announces appointment of Chief Commercial Officer
2020-11-30
Annual Reports and Related Documents::
2020-11-20
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2020-11-10
General Announcement::Press Release: iX Biopharma receives positive EMA Scientific Advice for Wafermine
2020-10-30
General Announcement::MINUTES OF ANNUAL GENERAL MEETING HELD ON 16 OCTOBER 2020
2020-10-30
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2020-10-23
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2020-10-19
General Announcement::Press Release: iX Biopharma obtains approval and registration of Silcap in Singapore
2020-10-16
REPL::Annual General Meeting::Voluntary
2020-10-14
REPL::Annual General Meeting::Voluntary
2020-09-30
Annual General Meeting::Voluntary
2020-09-30
Annual Reports and Related Documents::
2020-09-27
General Announcement::Press Release: iX Biopharma Secures TGA GMP Licence for Its Testing Laboratory
2020-09-20
General Announcement::iX Biopharma Secures Israel Patent for Waferix Drug Delivery Technology
2020-09-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2020-09-10
REPL::Placements::PROPOSED PLACEMENT - COMPLETION OF PLACEMENT
2020-09-10
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
«
Previous
1
2
3
4
5
»
Next
© 2025 Dividends.sg /
More Countries
© Owned by Little White Pte. Ltd.